Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium

A. H. Rosenbaum, T. Maruta, E. Richelson

Research output: Contribution to journalArticle

8 Scopus citations

Abstract

In the last two decades, there has been rapid progress in the pharmacologic treatment of affective disorders. In Part 1 of this review, drugs mainly used for depression (tricyclic antidepressants and monosamine oxidase inhibitors) were discussed. Here, lithium carbonate, the most effective drug for manic-depressive illness (bipolar depression) is the focus. Its indications, mode of action, pharmacokinetics, dosage, and side effects are discussed. A section on drug interactions with lithium deals with the combination effect of lithium used with antidepressant and other psychotropic agents.

Original languageEnglish (US)
Pages (from-to)401-407
Number of pages7
JournalMayo Clinic Proceedings
Volume54
Issue number6
StatePublished - 1979

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium'. Together they form a unique fingerprint.

  • Cite this

    Rosenbaum, A. H., Maruta, T., & Richelson, E. (1979). Series on pharmacology in practice. I. Drugs that alter mood. II. Lithium. Mayo Clinic Proceedings, 54(6), 401-407.